GENFIT S.A. (GNFT) Social Stream



GENFIT S.A. (GNFT): $3.76

0.04 (-1.05%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add GNFT to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#31 of 387

in industry

GENFIT SA (GNFT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering GNFT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-09-30 2 $15 $5 $9 $3.96 127.27%
2021-12-17 2 $15 $5 $9 $3.96 127.27%
2021-12-20 2 $15 $5 $9.333 $3.96 135.68%
2023-02-08 3 $10 $5 $7.666 $3.96 93.59%
2023-03-17 2 $10 $4 $7.333 $3.96 85.18%
2023-06-06 3 $9 $4 $5.666 $3.96 43.08%
2023-07-03 3 $11 $4 $6.333 $3.96 59.92%
2023-09-21 3 $11 $4 $7.666 $3.96 93.59%
2023-12-08 2 $11 $8 $9.5 $3.96 139.9%

The Trend in the Analyst Price Target


GNFT's average price target has moved up $1.83 over the prior 45 weeks.

GNFT reports an average of 105.58% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-17 3 10 4 7.333 4.21 74.18%
2023-04-17 3 9 4 5.666 3.88 46.03%
2023-06-06 3 9 4 5.666 4.32 31.16%
2023-08-24 3 11 4 7.666 3.30 132.3%
2023-09-21 2 11 8 9.500 3.37 181.9%

GNFT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 15 months, GNFT's average broker recommendation rating improved by 1.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • GENFIT SA's number of analysts covering the stock is higher than 55.6% of all US stocks.
  • In the context of all US stocks, GENFIT SA's average analyst price target is higher than 79.75% of them.
  • GENFIT SA's variance in analysts' estimates is lower than -671.02% of stocks in the small market cap category.
  • In the context of stocks in the small market cap category, GENFIT SA's upside potential (average analyst target price relative to current price) is greater than 541.83% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GENFIT SA are IMTX, STRO, and CLLS.

Is GNFT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!